Clinical Trial Update: Ultra-low Dose Oral Ketamine for Chronic Pain in the Primary Care Setting [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ultra-low dose oral ketamine for chronic pain in a primary care setting; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Washington | Conditions: Chronic Pain | Phase 3 | Status: UNKNOWN